| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.
|
JAMA
|
2008
|
7.50
|
|
2
|
Acute kidney injury increases risk of ESRD among elderly.
|
J Am Soc Nephrol
|
2008
|
6.91
|
|
3
|
Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001.
|
J Am Soc Nephrol
|
2006
|
6.86
|
|
4
|
Spectrum of acute renal failure in the intensive care unit: the PICARD experience.
|
Kidney Int
|
2004
|
6.04
|
|
5
|
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury.
|
Kidney Int
|
2009
|
4.72
|
|
6
|
Temporal trends in the prevalence of diabetic kidney disease in the United States.
|
JAMA
|
2011
|
4.70
|
|
7
|
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
|
N Engl J Med
|
2009
|
3.69
|
|
8
|
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.
|
Kidney Int
|
2004
|
2.81
|
|
9
|
Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus.
|
Clin J Am Soc Nephrol
|
2011
|
2.62
|
|
10
|
Timing of initiation of dialysis in critically ill patients with acute kidney injury.
|
Clin J Am Soc Nephrol
|
2006
|
2.56
|
|
11
|
Plasma cytokine levels predict mortality in patients with acute renal failure.
|
Kidney Int
|
2004
|
2.52
|
|
12
|
Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients.
|
Crit Care
|
2010
|
2.51
|
|
13
|
Donor kidney exchanges.
|
Am J Transplant
|
2004
|
2.39
|
|
14
|
Kidney disease and increased mortality risk in type 2 diabetes.
|
J Am Soc Nephrol
|
2013
|
2.28
|
|
15
|
Association between physical performance and all-cause mortality in CKD.
|
J Am Soc Nephrol
|
2013
|
2.26
|
|
16
|
Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease.
|
Intensive Care Med
|
2010
|
2.00
|
|
17
|
A prospective study of frailty in nephrology-referred patients with CKD.
|
Am J Kidney Dis
|
2012
|
1.90
|
|
18
|
Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy.
|
Am J Kidney Dis
|
2003
|
1.83
|
|
19
|
Balancing Fistula First with Catheters Last.
|
Am J Kidney Dis
|
2007
|
1.83
|
|
20
|
Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress.
|
Kidney Int
|
2004
|
1.66
|
|
21
|
Prediction, progression, and outcomes of chronic kidney disease in older adults.
|
J Am Soc Nephrol
|
2009
|
1.56
|
|
22
|
Acute kidney injury in older adults.
|
J Am Soc Nephrol
|
2011
|
1.54
|
|
23
|
Use of aspirin associates with longer primary patency of hemodialysis grafts.
|
J Am Soc Nephrol
|
2011
|
1.49
|
|
24
|
Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD.
|
J Am Soc Nephrol
|
2008
|
1.44
|
|
25
|
Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial.
|
J Am Soc Nephrol
|
2005
|
1.37
|
|
26
|
MCP-1 gene activation marks acute kidney injury.
|
J Am Soc Nephrol
|
2010
|
1.34
|
|
27
|
Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury.
|
Clin J Am Soc Nephrol
|
2009
|
1.33
|
|
28
|
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients.
|
Am J Kidney Dis
|
2007
|
1.32
|
|
29
|
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism.
|
Kidney Int
|
2013
|
1.31
|
|
30
|
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.
|
Clin Trials
|
2005
|
1.31
|
|
31
|
The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.
|
Kidney Int
|
2012
|
1.27
|
|
32
|
Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways.
|
J Clin Invest
|
2014
|
1.24
|
|
33
|
Urea space and total body water measurements by stable isotopes in patients with acute renal failure.
|
Kidney Int
|
2004
|
1.22
|
|
34
|
Association of major depression and mortality in Stage 5 diabetic chronic kidney disease.
|
Gen Hosp Psychiatry
|
2010
|
1.17
|
|
35
|
Technology Insight: biomarker development in acute kidney injury--what can we anticipate?
|
Nat Clin Pract Nephrol
|
2008
|
1.15
|
|
36
|
Sepsis and the kidney.
|
Crit Care Clin
|
2005
|
1.14
|
|
37
|
Insulin resistance in critically ill patients with acute renal failure.
|
Am J Physiol Renal Physiol
|
2005
|
1.13
|
|
38
|
ESRD impairs nonrenal clearance of fexofenadine but not midazolam.
|
J Am Soc Nephrol
|
2009
|
1.13
|
|
39
|
Advances in understanding ischemic acute kidney injury.
|
BMC Med
|
2011
|
1.11
|
|
40
|
Tubular expression of KIM-1 does not predict delayed function after transplantation.
|
J Am Soc Nephrol
|
2009
|
1.10
|
|
41
|
Hemodialysis acutely improves hepatic CYP3A4 metabolic activity.
|
J Am Soc Nephrol
|
2006
|
1.10
|
|
42
|
Physical activity and change in estimated GFR among persons with CKD.
|
J Am Soc Nephrol
|
2013
|
1.08
|
|
43
|
Success and challenge in dialysis therapy.
|
N Engl J Med
|
2002
|
1.06
|
|
44
|
Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease.
|
Pediatr Nephrol
|
2009
|
1.06
|
|
45
|
Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients.
|
Transplantation
|
2005
|
1.05
|
|
46
|
Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients.
|
Am J Clin Nutr
|
2007
|
1.03
|
|
47
|
Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis.
|
Clin J Am Soc Nephrol
|
2010
|
1.03
|
|
48
|
Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2007
|
1.01
|
|
49
|
World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease.
|
J Am Soc Nephrol
|
2009
|
1.00
|
|
50
|
Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury.
|
Nephrol Dial Transplant
|
2009
|
0.99
|
|
51
|
Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease.
|
Kidney Int
|
2012
|
0.99
|
|
52
|
Hemodialysis access failure: a call to action--revisited.
|
Kidney Int
|
2009
|
0.99
|
|
53
|
Dialysis therapies: a National Dialogue.
|
Clin J Am Soc Nephrol
|
2014
|
0.99
|
|
54
|
The chronic kidney disease initiative.
|
J Am Soc Nephrol
|
2004
|
0.97
|
|
55
|
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
|
Clin Trials
|
2005
|
0.96
|
|
56
|
Mechanisms of drug-induced nephrotoxicity.
|
Handb Exp Pharmacol
|
2010
|
0.95
|
|
57
|
ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities.
|
J Am Soc Nephrol
|
2010
|
0.94
|
|
58
|
Survival by dialysis modality in critically ill patients with acute kidney injury.
|
J Am Soc Nephrol
|
2006
|
0.93
|
|
59
|
Assessment of physical activity in chronic kidney disease.
|
J Ren Nutr
|
2012
|
0.92
|
|
60
|
Effect of hemodialysis on hepatic cytochrome P450 functional expression.
|
J Pharmacol Sci
|
2008
|
0.92
|
|
61
|
Reasons for non-enrollment in a cohort study of ARF: the Program to Improve Care in Acute Renal Disease (PICARD) experience and implications for a clinical trials network.
|
Am J Kidney Dis
|
2003
|
0.91
|
|
62
|
Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes.
|
Kidney Int
|
2009
|
0.90
|
|
63
|
Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
|
Curr Opin Nephrol Hypertens
|
2007
|
0.87
|
|
64
|
Primary mouse renal tubular epithelial cells have variable injury tolerance to ischemic and chemical mediators of oxidative stress.
|
Oxid Med Cell Longev
|
2009
|
0.87
|
|
65
|
Initiation of dialysis should be timely: neither early nor late.
|
Semin Dial
|
2013
|
0.86
|
|
66
|
Regional differences in dialysis care and mortality among American Indians and Alaska Natives.
|
J Am Soc Nephrol
|
2011
|
0.85
|
|
67
|
Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system.
|
Stem Cell Res Ther
|
2013
|
0.85
|
|
68
|
Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
|
Circ Heart Fail
|
2010
|
0.84
|
|
69
|
Simultaneous analysis of multiple aminothiols in human plasma by high performance liquid chromatography with fluorescence detection.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2009
|
0.84
|
|
70
|
Adverse effects of systemic glucose absorption with peritoneal dialysis: how good is the evidence?
|
Curr Opin Nephrol Hypertens
|
2013
|
0.84
|
|
71
|
Muscle wasting in kidney disease: Let's get physical.
|
J Am Soc Nephrol
|
2006
|
0.83
|
|
72
|
The patient-centered medical home and nephrology.
|
J Am Soc Nephrol
|
2009
|
0.83
|
|
73
|
Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease.
|
J Ren Nutr
|
2010
|
0.82
|
|
74
|
Developing microphysiological systems for use as regulatory tools--challenges and opportunities.
|
ALTEX
|
2014
|
0.82
|
|
75
|
Characteristics and performance of minority-serving dialysis facilities.
|
Health Serv Res
|
2013
|
0.82
|
|
76
|
Dose-ranging trial with a recombinant urokinase (urokinase alfa) for occluded central venous catheters in oncology patients.
|
J Vasc Interv Radiol
|
2004
|
0.81
|
|
77
|
HMG-CoA reductase activation and urinary pellet cholesterol elevations in acute kidney injury.
|
Clin J Am Soc Nephrol
|
2011
|
0.81
|
|
78
|
Determinants of plasma adiponectin levels in nondiabetic subjects with moderate to severe chronic kidney disease.
|
J Ren Nutr
|
2009
|
0.81
|
|
79
|
Ironing out the pathogenesis of acute kidney injury.
|
Am J Kidney Dis
|
2009
|
0.81
|
|
80
|
Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease.
|
Clin J Am Soc Nephrol
|
2010
|
0.80
|
|
81
|
Homelessness and CKD: a cohort study.
|
Clin J Am Soc Nephrol
|
2012
|
0.80
|
|
82
|
Toward the optimal dose metric in continuous renal replacement therapy.
|
Int J Artif Organs
|
2012
|
0.80
|
|
83
|
Uremic retention solutes: the free and the bound.
|
J Am Soc Nephrol
|
2007
|
0.80
|
|
84
|
Periodontitis associated with chronic kidney disease among Mexican Americans.
|
J Public Health Dent
|
2012
|
0.79
|
|
85
|
Tragic options and compromised care: undocumented immigrants with ESRD.
|
Am J Kidney Dis
|
2012
|
0.79
|
|
86
|
The inexorable rise of AKI: can we bend the growth curve?
|
J Am Soc Nephrol
|
2012
|
0.79
|
|
87
|
Medicare ESRD prospective payment system: weighing the evidence.
|
J Am Soc Nephrol
|
2005
|
0.78
|
|
88
|
Antioxidant therapy in uremia: evidence-based medicine?
|
Semin Dial
|
2004
|
0.78
|
|
89
|
Human resources, training, and the growing worldwide epidemic of kidney disease: introduction.
|
Semin Nephrol
|
2009
|
0.78
|
|
90
|
Homelessness and risk of end-stage renal disease.
|
J Health Care Poor Underserved
|
2014
|
0.77
|
|
91
|
Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD).
|
Hemodial Int
|
2014
|
0.77
|
|
92
|
Changes in symptom burden and physical performance with initiation of dialysis in patients with chronic kidney disease.
|
Hemodial Int
|
2014
|
0.76
|
|
93
|
Optimizing patient safety during hemodialysis.
|
JAMA
|
2011
|
0.76
|
|
94
|
Trials and trade-offs in haemodialysis vascular access monitoring.
|
Nephrol Dial Transplant
|
2006
|
0.76
|
|
95
|
Dialysis in 2012: Could longer and more frequent haemodialysis improve outcomes?
|
Nat Rev Nephrol
|
2013
|
0.76
|
|
96
|
Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.
|
Physiol Rep
|
2014
|
0.76
|
|
97
|
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
|
N Engl J Med
|
2014
|
0.76
|
|
98
|
The ABCs of micronutrients in dialysis patients.
|
Am J Kidney Dis
|
2010
|
0.75
|
|
99
|
Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.
|
Nephron Clin Pract
|
2005
|
0.75
|
|
100
|
What is the current and future status of interventional nephrology?
|
Semin Dial
|
2005
|
0.75
|
|
101
|
Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis.
|
Kidney Int
|
2003
|
0.75
|
|
102
|
Corrigendum: Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle.
|
Sci Rep
|
2017
|
0.75
|
|
103
|
Online hemodiafiltration: back to the future?
|
Artif Organs
|
2006
|
0.75
|
|
104
|
Cost-effectiveness of antiplatelet therapy to prolong primary patency of hemodialysis graft.
|
Clin Nephrol
|
2014
|
0.75
|
|
105
|
Safety of low volume iodinated contrast administration for arteriovenous fistula intervention in chronic kidney disease stage 4 or 5 utilizing a bicarbonate prophylaxis strategy.
|
Semin Dial
|
2010
|
0.75
|
|
106
|
1372: DEVELOPMENT OF A ROBUST BIOMARKER PREDICTIVE MODEL FOR DEATH IN ICU PATIENTS WITH SIRS AND SEPSIS.
|
Crit Care Med
|
2016
|
0.75
|
|
107
|
World Kidney Day 2008: think globally, speak locally.
|
J Am Soc Nephrol
|
2008
|
0.75
|